Effects of Beta Lactams on Behavioral Outcomes of Substance Use Disorders: A Meta-Analysis of Preclinical Studies-Reference-Cited by-同舟云学术

Effects of Beta Lactams on Behavioral Outcomes of Substance Use Disorders: A Meta-Analysis of Preclinical Studies

Published:2024-01 Issue: Volume:537 Page:58-83
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Alasmari Mohammed S.,Almohammed Omar A.,Hammad Alaa M.^ORCID,Altulayhi Khalid A.,Alkadi Bader K.,Alasmari Abdullah F.,Alqahtani Faleh,Sari Youssef,Alasmari Fawaz^ORCID

Funder

King Saud University

Publisher

Elsevier BV

Subject

General Neuroscience

Reference136 articles.

1. Abramson, A., 2021. Substance use during the pandemic. American Psychological Association 52, 22. Available at: https://www.apa.org/monitor/2021/03/substance-use-pandemic.

2. Ceftriaxone as a novel therapeutic agent for hyperglutamatergic states: Bridging the gap between preclinical results and clinical translation;Abulseoud;Front Neurosci,2022

3. Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2;Abulseoud;Neuropsychopharmacology,2014

4. Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm;Abulseoud;Brain Res,2012

5. Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice;Alajaji;Psychopharmacology,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroinflammation and Neurometabolomic Profiling in Fentanyl Overdose Mouse Model Treated with Novel β-Lactam, MC-100093, and Ceftriaxone;Toxics;2024-08-19